NOMETHROMAX

This brand name is authorized in Nigeria.

Active ingredients

The drug NOMETHROMAX contains one active pharmaceutical ingredient (API):

1	Azithromycin UNII 5FD1131I7S - AZITHROMYCIN DIHYDRATE
	Azithromycin is a macrolide antibiotic belonging to the azalide group. The molecule is constructed by adding a nitrogen atom to the lactone ring of erythromycin A. The mechanism of action of azithromycin is based upon the suppression of bacterial protein synthesis by means of binding to the ribosomal 50S sub-unit and inhibition of peptide translocation.
	Read more about Azithromycin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-7858	Tablet	Nomethromax 250 mg Tablets TAB 250 mg 1 x 6's (in PVC-Alu blister)	Tablet 28 RNW-PP-289209 NOMETHROMAX 250MG TABLETS AZITHROMYCIN Composition: Each film-coated tablet contains: Azithromycin Dihydrate USP Equivalent to Azithromycin ……. 250 mg Excipients…………………………q.s. Colour: Titanium Dioxide Strength: Azithromycin Dihydrate USP Equivalent to Azithromycin B4-7858 Drugs Imported Products 1x6 Prescription Only Medicine (POM) 11/10/2022 NOMEDI PHARMACEUTICALS LIMITED, 387 Agege motor road Mushin 17412135 victoria.ezeala@nomedipharma-ng.com Coral Laboratories limited, plot no 57 /1 (16) bhenslore, dunetha nani daman - 396 210, India	27/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01FA10	Azithromycin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FA Macrolides
Discover more medicines within J01FA10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-7858